Literature DB >> 18594830

Non-invasive and minimally invasive staging of regional lymph nodes in penile cancer.

Ben Hughes1, Joost Leijte, Majid Shabbir, Nick Watkin, Simon Horenblas.   

Abstract

INTRODUCTION: The management of the regional lymph nodes in penile cancer patients, particularly when these lymph nodes are impalpable, remains controversial. Prophylactic bilateral inguinal lymphadenectomy is associated with high morbidity and is often unnecessary. However, there is no non-invasive or minimally invasive staging technique that can determine the lymph node status of penile cancer patients with 100% accuracy.
METHODS: We reviewed the current literature to examine the role of non-invasive and minimally invasive techniques for staging regional lymph nodes in penile cancer with particular reference to clinically impalpable disease.
RESULTS: Cross-sectional imaging (un-enhanced CT and MRI) modalities have a role in the assessment of patients with palpable inguinal basins and in locating distant metastases, but are unreliable in staging impalpable regional lymph nodes. The spatial resolution of lymphotropic nanoparticle enhanced MRI (LNMRI) and positron emission tomography (PET)/CT are limited to several millimetres and so these modalities cannot reliably detect micro-metastases (<2 mm). Ultrasound (US) and fine-needle aspiration cytology (FNAC) are indicated in staging palpable inguinal basins but are unreliable in isolation in the assessment of impalpable lymph nodes. They are, however, useful as an adjunct to dynamic sentinel lymph node biopsy (DSLNB) in lowering false-negative rates.
CONCLUSIONS: While we await staging modalities that can equal the results of DSLNB with fewer disadvantages, histological staging in the form of DSLNB remains the best minimally invasive staging modality we can offer at risk patients presenting with clinically node negative groins.

Entities:  

Mesh:

Year:  2008        PMID: 18594830     DOI: 10.1007/s00345-008-0288-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  42 in total

1.  Nomogram predictive of pathological inguinal lymph node involvement in patients with squamous cell carcinoma of the penis.

Authors:  Vincenzo Ficarra; Filiberto Zattoni; Walter Artibani; Andrea Fandella; Guido Martignoni; Giacomo Novara; Tommaso Prayer Galetti; Tiziano Zambolin; Michael W Kattan
Journal:  J Urol       Date:  2006-05       Impact factor: 7.450

Review 2.  Ultrasound of superficial lymph nodes.

Authors:  Gul Esen
Journal:  Eur J Radiol       Date:  2006-02-15       Impact factor: 3.528

3.  Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma.

Authors:  A Lopes; B M Rossi; F P Fonseca; S Morini
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

4.  Results and 10-year follow-up in patients with squamous cell carcinoma of the penis.

Authors:  P Derakhshani; S Neubauer; M Braun; H Bargmann; A Heidenreich; U Engelmann
Journal:  Urol Int       Date:  1999       Impact factor: 2.089

5.  A prospective study of 100 cases of penile cancer managed according to European Association of Urology guidelines.

Authors:  Paul K Hegarty; Oliver Kayes; Alex Freeman; Nim Christopher; David J Ralph; Suks Minhas
Journal:  BJU Int       Date:  2006-09       Impact factor: 5.588

Review 6.  Advanced penile carcinoma.

Authors:  Daniel J Culkin; Tomasz M Beer
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

7.  Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.

Authors:  S Horenblas; H van Tinteren; J F Delemarre; L M Moonen; V Lustig; E W van Waardenburg
Journal:  J Urol       Date:  1993-03       Impact factor: 7.450

8.  Carcinoma of the penis: improved survival by early regional lymphadenectomy based on the histological grade and depth of invasion of the primary lesion.

Authors:  W S McDougal
Journal:  J Urol       Date:  1995-10       Impact factor: 7.450

9.  Preoperative lymphoscintigraphy and dynamic sentinel node biopsy for staging penile cancer: results with pathological correlation.

Authors:  Philippe E Spiess; Jonathan I Izawa; Roland Bassett; Daniel Kedar; Joseph E Busby; Franklin Wong; Teresa Eddings; Pheroze Tamboli; Curtis A Pettaway
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

10.  Penile cancer: relation of extent of nodal metastasis to survival.

Authors:  V Srinivas; M J Morse; H W Herr; P C Sogani; W F Whitmore
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450

View more
  23 in total

Review 1.  Advanced penile cancer.

Authors:  Jonathan E Heinlen; David D Buethe; Daniel Joseph Culkin
Journal:  Int Urol Nephrol       Date:  2011-08-04       Impact factor: 2.370

2.  Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

Authors:  Suzanne Richter; J Dean Ruether; Lori Wood; Christina Canil; Patricia Moretto; Peter Venner; Joel Gingerich; Urban Emmenegger; Andrea Eisen; Pawel Zalewski; Anthony Joshua; Som Dave Mukherjee; Daniel Heng; Piotr Czaykowski; Denis Soulieres; Norman Blais; Ricardo Rendon; Neil Fleshner; Juanita M Crook; Srikala S Sridhar
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

3.  Sentinel lymph node in patients with rectal cancer invading the anal canal.

Authors:  D C Damin; G C Tolfo; M A Rosito; B L Spiro; L M Kliemann
Journal:  Tech Coloproctol       Date:  2010-04-28       Impact factor: 3.781

4.  Inguinal Lymph Nodes in Carcinoma Penis-Observation or Surgery?

Authors:  Syed Althaf; Rajkumar P Narayanakar; Dinesh M Gangaiah; Kapil Dev; Vishnu P Kurpad; Jaiprakash Gurawalia
Journal:  J Clin Diagn Res       Date:  2016-01-01

5.  Penile cancer: Optimal management of T1G2 penile cancer remains unclear.

Authors:  Alcides Chaux; Antonio L Cubilla
Journal:  Nat Rev Urol       Date:  2012-12-11       Impact factor: 14.432

6.  The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection.

Authors:  Jian-Ye Liu; Yong-Hong Li; Zhi-Ling Zhang; Kai Yao; Yun-Lin Ye; Dan Xie; Hui Han; Zhou-Wei Liu; Zi-Ke Qin; Fang-Jian Zhou
Journal:  World J Urol       Date:  2013-02-28       Impact factor: 4.226

7.  18F-FDG PET/CT as a prognostic factor in penile cancer.

Authors:  André Salazar; Eduardo Paulino Júnior; Paulo Guilherme O Salles; Raul Silva-Filho; Edna A Reis; Marcelo Mamede
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-24       Impact factor: 9.236

Review 8.  [Relevance of radiological imaging for lymph node surgery of urological tumors].

Authors:  J Stattaus; M Forsting
Journal:  Urologe A       Date:  2009-01       Impact factor: 0.639

9.  Factors predicting inguinal node metastasis in squamous cell cancer of penis.

Authors:  Suresh K Bhagat; Ganesh Gopalakrishnan; Nitin S Kekre; Ninan K Chacko; Santosh Kumar; M T Manipadam; Prasanna Samuel
Journal:  World J Urol       Date:  2009-06-02       Impact factor: 4.226

10.  Penile cancer: Clinical Practice Guidelines in Oncology.

Authors:  Peter E Clark; Philippe E Spiess; Neeraj Agarwal; Matthew C Biagioli; Mario A Eisenberger; Richard E Greenberg; Harry W Herr; Brant A Inman; Deborah A Kuban; Timothy M Kuzel; Subodh M Lele; Jeff Michalski; Lance Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Jerome P Richie; Wade J Sexton; William U Shipley; Eric J Small; Donald L Trump; Geoffrey Wile; Timothy G Wilson; Mary Dwyer; Maria Ho
Journal:  J Natl Compr Canc Netw       Date:  2013-05-01       Impact factor: 11.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.